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I thank the author for the letter “Moderate to 
severe ischemic mitral regurgitation: More data 
to guide the choice. Why not consider the use 
of subvalvular repair?” [1]. As presented in the 
original article “Long-term outcomes of mitral 
valve annuloplasty versus subvalvular sparing 
replacement for severe ischemic mitral regurgita-
tion” [2], ring annuloplasty (RA) was performed 
without subvalvular repair, which was in according 
with the practice guidelines [3]. In addition, it was 
found that compared with the mitral valve replace-
ment group, the incidence of mitral regurgitation 
recurrence was significantly higher in the RA group 
(p < 0.001) [3].
Ischemic mitral regurgitation (MR) is fre-
quently associated with myocardial infarction. With 
the dilatation of the ventricle, the papillary muscles 
are displaced, and the leaflets are pulled downward 
and laterally. In the most frequent inferior infarc-
tion, this leaflet tethering is observed in the area of 
the posteromedial commissure. What is more, the 
annulus dilates secondarily to both the dilatation 
of the ventricle and the MR, which enters a vicious 
cycle [3, 4, 5]. According to practice guidelines, 
mitral valve (MV) repair with an undersized com-
plete rigid annuloplasty ring may be considered 
in patient with severe ischemic MR who remain 
symptomatic despite guideline directed medical 
and cardiac device therapy and who do not have 
a basal aneurysm/dyskinesis, significant leaflet 
tethering, or severe left ventricular enlargement 
(COR IIb, LOE B) [3]. Though there are different 
kinds of techniques for MV repair, such as annu-
loplasty and subannular repair [4, 6–9], guidelines 
do not specifically point out which of the currently 
available valve repair approaches are superior. In 
accordance with practice guidelines, the technique 
of RA was easy-to-accomplish, effective and safe, 
it is also common at the documented center, these 
results are shown in a retrospective study [2].
According to the Alain Carpentier functional 
classification, MR of type I is characterized by an-
nular dilation, while type IIIb is characterized by 
restricted motion of the leaflets because of tether-
ing [8, 10]. As documented in the results of recent 
studies, both of type I and type IIIb are common 
for ischemic MR, and ischemic MR is a secondary 
pathology where the underlying mechanism is 
not eradicated by either subannular repair or RA 
alone [4, 5]. 
Undersized RA. Undersized RA is designed to 
correct MR of type I. Although it is perhaps less tech-
nically challenging and associated with lower short-
term complication rates, the high rate of recurrent 
MR after repair attenuates the potential benefit of RA. 
Several studies have suggested that posterior leaflet 
tethering after undersized RA is the main underlying 
mechanism associated with MR recurrence [7, 10]. 
Capoulade et al. [10] concluded that left ventricular 
ring mismatch was associated with significant recur-
rent MR in patients after undersized RA.
Subannular repair. Because misalignment 
of the papillary muscles appears to be the main 
problem, techniques directed at papillary muscle 
realignment have been suggested, and two tech-
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1. Pausch et al. [8] proposed a modified subannu-
lar maneuver to correct type IIIb MR while 
combining undersized RA with a controlled 
realignment of both papillary muscles, thereby 
fixing the distance between mitral annular 
plane and papillary muscle tips. Double-armed 
pledgeted 3–0 Polytetrafluorethylene sutures 
were passed through the trunks of both papil-
lary muscles in a U-formed fashion, and then 
both suture ends were subsequently passed 
through the posterior mitral valve annulus and 
the annuloplasty ring (i.e., in the P1 segment 
for anterolateral papillary muscle and in the 
P3 segment for posteromedial papillary muscle) 
from the ventricular to atrial side. Though 
they concluded that this technique was feasi-
ble and reproducible, having a clear potential 
to significantly decrease MR recurrence and 
improve 1-year outcome compared to isolated 
annuloplasty, one should be aware of the risk 
of papillary muscle injuries. 
2. With the technique of papillary muscle approx-
imation, Nappi et al. [9] carried a randomized 
study aimed at elucidating the effective ben-
efit of papillary muscle surgery in long-term 
follow-up. Finally, compared with under sizing 
RA only, papillary muscle approximation with 
under sizing RA exerted a long-term beneficial 
effect on left ventricular remodeling, which 
improved long-term cardiac outcome, but did 
not produce differences in overall mortality or 
quality of life. Though the benefits of papillary 
muscle approximation seemed to be remark-
able, the percentage of moderate-to-severe 
MR recurrence was still as high as 27%. Of 
note, in the condition of severely adverse left 
ventricular remodeling, both of the papillary 
muscles might be displaced significantly. As 
a result, the technique of papillary muscle ap-
proximation could not relieve leaflet tethering 
effectively.
As no consensus regarding the most appro-
priate surgical strategy for subannular repair is 
available so far, more studies should be carried 
out. In addition, it should be verified whether the 
technique of papillary muscle approximation with 
RA is superior to mitral valve replacement.
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